Enanta PharmaceuticalsENTA 
$11.66-1.27%24h
-1.27%24h
Global rank16028
Market cap$244.50M
Change 7d-5.74%
YTD Performance25.11%
SP500 benchmarkOutperform
P/E-1.83
P/S3.09
Revenue$79.20M
Earnings-$133.82M
Dividend yield-
Main Sector
Healthcare
Category
Enanta Pharmaceuticals (ENTA) Cash on Hand
ENTA Cash on Hand in 2022: $369.91M
According to Enanta Pharmaceuticals latest financial reports the cash on hand of ENTA is $369.91M, an increase of 48.42% to 2022. At the end of 2022 company had $249.23M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
ENTA Cash on Hand History from 2018 to 2023
-
Value:-
ENTA Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $369.91M | 48.42% |
| 2022 | $249.23M | 2.14% |
| 2021 | $244.00M | -36.89% |
| 2020 | $386.65M | 15.34% |
| 2019 | $335.24M | 8.59% |
| 2018 | $308.73M | - |
View the Top Cash on Hand Companies 
